Overview

* SelectQuote fiscal Q1 2026 revenue of $328.8 mln beats analyst expectations

* Net loss for fiscal Q1 2026 reduced to $30.5 mln from $44.5 mln last year

* Adjusted EBITDA for fiscal Q1 2026 was $(32.1) mln, down from $(1.7) mln last year

Outlook

* SelectQuote ( SLQT ) maintains fiscal 2026 revenue outlook of $1.65 bln to $1.75 bln

* Company expects Healthcare Services adjusted EBITDA around breakeven in fiscal Q2

* SelectQuote ( SLQT ) anticipates Healthcare Services adjusted EBITDA run rate of $40 to $50 mln by fiscal year-end

Result Drivers

* SENIOR SEGMENT CHALLENGES - Revenue and adjusted EBITDA declined due to a decrease in Medicare Advantage policies

* HEALTHCARE SERVICES GROWTH - Revenue and adjusted EBITDA increased, driven by a 24% rise in SelectRx members and higher pharmacy revenue

* LIFE SEGMENT PERFORMANCE - Revenue grew by 19% but adjusted EBITDA declined slightly

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q1 Beat $328.80 $318.99

Revenue mln mln (3

Analysts

)

Q1 Net -$30.50

Income mln

Q1 -$32.10

Adjusted mln

EBITDA

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the multiline insurance & brokers peer group is "buy"

* Wall Street's median 12-month price target for SelectQuote Inc ( SLQT ) is $5.50, about 61.3% above its November 5 closing price of $2.13

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)